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Nonalcoholic fatty liver disease is the most com-
mon chronic liver disorder in developed countries.
Its pathogenesis is poorly understood, and thera-
peutic options are limited. Here, we show that
SIRT7, an NAD+-dependent H3K18Ac deacetylase,
functions at chromatin to suppress ER stress and
prevent the development of fatty liver disease.
SIRT7 is induced upon ER stress and is stabilized
at the promoters of ribosomal proteins through
its interaction with the transcription factor Myc to
silence gene expression and to relieve ER stress.
SIRT7-deficient mice develop chronic hepatos-
teatosis resembling human fatty liver disease. Myc
inactivation or pharmacological suppression of ER
stress alleviates fatty liver caused by SIRT7 defi-
ciency. Importantly, SIRT7 suppresses ER stress
and reverts the fatty liver disease in diet-induced
obese mice. Our study identifies SIRT7 as a
cofactor of Myc for transcriptional repression and
delineates a druggable regulatory branch of the
ER stress response that prevents and reverts fatty
liver disease.654 Cell Reports 5, 654–665, November 14, 2013 ª2013 The AuthorsINTRODUCTION
Nonalcoholic fatty liver disease (NAFLD) affects one-third of
adults and an increasing number of children in developed coun-
tries and is strongly associated with obesity and insulin resis-
tance (Browning and Horton, 2004; Browning et al., 2004; Cohen
et al., 2011). NAFLD begins with aberrant accumulation of tri-
glyceride in the liver (steatosis). Hepatic steatosis can proceed
to nonalcoholic steatohepatitis (NASH), a condition associated
with hepatocyte injury, inflammation, and fibrosis. Steatohepati-
tis can further progress to cirrhosis and liver cancer (Argo and
Caldwell, 2009; Starley et al., 2010).
The endoplasmic reticulum (ER) stress response (also known
as the unfolded protein response [UPRER]), a signal transduction
pathway that is activated in response to the accumulation of
unfolded proteins in the ER, has emerged as a critical regulator
of lipid homeostasis in the liver (Basseri and Austin, 2012;
Cnop et al., 2012; Fu et al., 2012; Hotamisligil, 2010; Ozcan
and Tabas, 2012). The initial phase of the UPRER is suppression
of protein translation and increased production of molecular
chaperones to promote protein folding, allowing the cells to
cope with an increased protein-folding demand and restore pro-
tein homeostasis (Hetz, 2012; Walter and Ron, 2011). Prolonged
ER stress has been implicated in the development of numerous
diseases, including fatty liver disease (Hotamisligil, 2010; Ozcan
and Tabas, 2012). Identification of crucial UPR regulators with
precise ER-stress-relieving properties that are amenable for
therapeutic targeting represents attractive opportunities for
pharmacological intervention of fatty liver and a wide spectrum
of human diseases.
The sirtuin family of nicotinamide adenine dinucleotide
(NAD+)-dependent deacetylases is profoundly implicated in
metabolic regulation (Bellet et al., 2011; Finkel et al., 2009; Gillum
et al., 2010; Hirschey et al., 2011; Houtkooper et al. 2012; Imai
and Guarente, 2010). Sirtuins are well-sought-after drug targets
for metabolic disorders, as their enzymatic activities are
amenable for regulation (Baur et al., 2012). SIRT7, a histone H3
lysine 18 (H3K18) deacetylase that binds to the promoters of a
specific set of gene targets for transcriptional repression (Barber
et al., 2012), is the only mammalian sirtuin whose function in
metabolic regulation remains unknown.
We set out to fill this gap in knowledge by asking whether
SIRT7 governs metabolic homeostasis under physiological con-
ditions. Here, we show that SIRT7 has a physiological function in
metabolic regulation that occurs through a chromatin-depen-
dent signaling pathway that maintains metabolic homeostasis.
Finally, we show that SIRT7 can be targeted to restore metabolic
homeostasis in animals with metabolic disorders.
RESULTS
SIRT7-Deficient Mice Develop Steatosis Resembling
Human Fatty Liver Disease
Among themetabolic tissues, SIRT7 is themost highly expressed
in the liver (Ford et al., 2006). To gain insight into SIRT7 function,
we generated SIRT7 knockout (KO)mice (Figures 1A and 1B; Fig-
ure S1A). Livers of SIRT7 KO mice fed a chow diet appeared
paler and slightly larger than the wild-type (WT) controls with
100% penetrance (Figures 1C and S1B). Hematoxylin and eosin
(H&E) staining showed that SIRT7 KO hepatocytes were mark-
edly vacuolated, with the accumulated material staining positive
for fat with the Oil Red O stain (Figure 1C). Quantification of the
triglyceride extracted from the livers by a colorimetric assay
showed that SIRT7 KO livers had a 2.5-fold increase in triglyc-
eride content (Figure 1D). Compared to the WT controls, the
livers of SIRT7 KO mice had increased expression of inflamma-
tory markers (Figure 1E), and immunohistochemistry showed
increased staining for F4/80 (Figure 1C), a marker for tissue
macrophages, indicating the progression to steatohepatitis.
Notably, although fatty liver disease is often associated with
obesity (Cohen et al., 2011; Ozcan et al., 2006), SIRT7 KO mice
were leaner than littermate controls (Figures S1C and S1D).
Thus, SIRT7 deficiency results in fatty liver without obesity.
Next, we investigated the lipid metabolic pathways in SIRT7
KO livers. The expression of lipogenic genes was increased
in SIRT7 KO livers compared to the WT controls, whereas the
expression of genes in the fatty acid oxidation pathway was un-
changed (Figure 1E), suggesting that increased lipogenesis may
be a contributing factor for hepatosteatosis. Despite increased
lipid content in the livers of SIRT7 KOmice (Figure 1D), the levels
of plasma triglyceride were 4-fold lower in SIRT7 KO mice
compared to WT controls (Figure S1E). Reduced plasma triglyc-
erides in SIRT7 KO mice is not due to reduced food intake or
malabsorption of lipid (Figures S1F and S1G), suggesting thatCeSIRT7 KO mice may have reduced very-low-density lipoprotein
(VLDL) secretion, the lipoprotein responsible for hepatic lipid
export. In a well-established VLDL-TG secretion assay, SIRT7
KO mice had a 50% reduction in VLDL-TG secretion (Figure 1F).
Quantification of the VLDL particles (sizes ranging from 250–
550 A˚) using a gas-phase differential electrical mobility analyzer
showed greatly reduced VLDL concentration in the blood of
SIRT7 KO mice compared to the WT controls (Figure 1G).
Together, these data indicate that SIRT7 KO mice develop
fatty liver because of increased lipogenesis and reduced VLDL
secretion.
Hepatic SIRT7Autonomously Prevents theDevelopment
of Fatty Liver
To investigate whether the fatty liver phenotype of SIRT7 KO
mice is due to SIRT7 deficiency in the liver or systemic effects
of SIRT7 deletion, we reintroduced SIRT7 specifically in the livers
of SIRT7 KO mice via adenoassociated virus 8 (AAV8)-mediated
gene transfer (Figure 2A). Strikingly, liver-specific reconstitution
of SIRT7 in SIRT7 KO mice reversed the fatty liver phenotype
(Figures 2B–2D), suppressed hepatic inflammation and lipogen-
esis (Figure 2E), and rescued the VLDL-TG secretion defect (Fig-
ure 2F). Importantly, this reversal of hepatosteatosis was not due
to unphysiological levels of SIRT7 overexpression, because the
reconstituted expression of SIRT7 was comparable to endoge-
nous levels (Figure 2A). Together, these data indicate that hepat-
ic SIRT7 autonomously prevents the development of fatty liver.
SIRT7 Activation Is a Critical Event of the UPR to
Alleviate ER Stress
Activation of the UPR pathways induces inflammation (Hotami-
sligil, 2010), perturbs hepatic lipid metabolism by modulating
lipogenesis and lipoprotein metabolism (Kammoun et al., 2009;
Lee et al., 2008; Ota et al., 2008; Rutkowski et al., 2008; So
et al., 2012; Wang et al., 2012; Zhang et al., 2011), and results
in the development of fatty liver, reminiscent of essential aspects
of SIRT7 KO phenotype in the liver (Figure 1). We therefore
hypothesized that SIRT7 might be an essential regulator of the
UPR. ER stress triggers finely regulated signaling events and
transcriptional activation of ER stress response target genes
with well-defined cis-elements (Hetz, 2012; Walter and Ron,
2011). Analysis of the SIRT7 promoter using MATInspector iden-
tified potential binding elements for XBP1, a key regulator of the
UPR, that preferentially binds to sequences containing an ACGT
core (Figure S2A) (Acosta-Alvear et al., 2007; Sha et al., 2009).
Thus, SIRT7 may be transcriptionally upregulated upon ER
stress. Indeed, treatment with chemical inducers of ER stress,
tunicamycin and thapsigargin, increased the expression of
SIRT7 at both the mRNA and protein levels in various cell types
(Figures 3A and 3B; Figures S2B–S2D). However, ER stress did
not induce SIRT7 expression in XBP1 KO mouse embryonic
fibroblasts (MEFs) (Figures 3A and 3B). Furthermore, ectopic
expression of the spliced XBP1 (XBP1s), the active form of
XBP1, induced SIRT7 expression to the same degree as it
induced Erdj4, a known XBP1s target (Figures S2E and S2F).
Additionally, in a luciferase assay, XBP1s induced transcrip-
tion driven by the SIRT7 promoter, but not the SIRT3 promoter
(Figure S2G). SIRT7 activity is dependent on NAD+, butll Reports 5, 654–665, November 14, 2013 ª2013 The Authors 655
Figure 1. SIRT7 Prevents the Development of Fatty Liver Disease
(A) Schematic representation of the SIRT7 locus and the SIRT7 KO-targeting vector.
(B) Southern blot confirming the generation of SIRT7 KO mice.
(C) Morphology, H&E staining, Oil Red O staining, and F4/80 staining showing increased lipid accumulation and inflammation in the livers of SIRT7 KO mice
compared to WT controls.
(D) Quantification of triglyceride extracted from livers in a colorimetric assay showing increased triglyceride content in SIRT7 KO livers. n = 6.
(E) Gene expression analysis by quantitative PCR showing increased inflammation and lipogenesis, but not fatty acid oxidation in SIRT7 KO livers. n = 4.
(F) A VLDL-TG secretion assay showing defective VLDL-TG secretion for SIRT7 KO mice. n = 6.
(G) Quantification of VLDL particle concentration in the blood using a gas-phase differential electrical mobility analyzer showing reduced VLDL particle
concentration in the blood of SIRT7 KO mice. n = 6.
Error bars represent SEM. * p < 0.05. ** p < 0.01. *** p < 0.001. ns: p > 0.05. See also Figure S1.tunicamycin treatment did not change the cellular NAD+ levels
(Figure S2H). Thus, SIRT7 is induced transcriptionally by XBP1
upon ER stress.656 Cell Reports 5, 654–665, November 14, 2013 ª2013 The AuthorsNext, we tested the effects of altered SIRT7 levels on ER
stress. Overexpression of SIRT7 substantially reduced ER stress
in response to tunicamycin, as evidenced by the reduced eIF2a
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Figure 2. Hepatic SIRT7 Prevents the Devel-
opment of Fatty Liver Autonomously
(A–F) Data shown are the comparison for the livers
of WT, SIRT7 KO, and SIRT7 KO mice expressing
SIRT7 in livers via AAV8-mediated gene transfer.
(A) Western analysis for SIRT7 expression. (B)
Liver morphology. (C) Liver triglyceride quantifi-
cation. (D) H&E and Oil Red O staining. (E) Gene
expression by quantitative PCR showing that
SIRT7 expression in liver suppresses hepatic
inflammation and lipogenesis of SIRT7 KO mice.
(F) In a VLDL-TG secretion assay, SIRT7 expres-
sion in liver rescued VLDL-TG secretion defects of
SIRT7 KO mice. n = 4.
Error bars represent SEM. * p < 0.05. ** p < 0.01.
*** p < 0.001. ns: p > 0.05.phosphorylation and expression of ER stress response genes
(Figures 3C–3F; Figures S2I and S2J). A catalytically inactive
SIRT7 mutant (H187Y) did not suppress ER stress (Figures
3C–3F), linking the catalytic activity of SIRT7 to ER stress man-
agement. To determine whether endogenous SIRT7 prevents
ER stress, we stably knocked down SIRT7 expression using
two independent short hairpin RNAs that specifically target
SIRT7. SIRT7 depletion led to constitutive induction of ER stress
(Figures 3G and S2K). Similarly, ER stress response genes were
also upregulated in SIRT7 KO MEFs (Figure 3H). ER stress
induces a reduction in the polysome-to-monosome ratio, indic-
ative of translational initiation blockade (Kawai et al., 2004).
Ribosomal profiling via a sucrose gradient showed that in
contrast toWTMEFs, which had a high polysome-to-monosome
ratio, SIRT7 KO MEFs had a reduction in polysomes and an
increase in low-molecular-weight monosomes, consistent with
increased ER stress in SIRT7 KO MEFs (Figure 3I). SIRT7 also
suppressed ER stress-induced cell death (Figures 3J, 3K, S2L,
and S2M), but not general apoptosis (Figures S2N and S2O).Cell Reports 5, 654–665, NTogether, these data suggest that SIRT7
activation is a critical event of the UPR
to alleviate ER stress.
Myc Recruits SIRT7 to Repress the
Expression of Ribosomal Proteins
and to Suppress ER Stress
How does SIRT7 regulate the UPR?
The initial phase of the UPR is suppres-
sion of protein translation and increased
production of molecular chaperones to
re-establish homeostasis (Hetz, 2012;
Walter and Ron, 2011). SIRT7 deacety-
lates H3K18Ac at specific gene pro-
moters to repress transcription, and a
major class of SIRT7-target genes are
involved in protein translation and ribo-
some biogenesis (Barber et al., 2012).
Thus, SIRT7 may alleviate ER stress by
suppressing ribosome biogenesis and
protein translation. Although SIRT7 lacks
known DNA binding motifs, previouswork has shown that it is recruited to a subset of its target pro-
moters via interaction with the transcription factor ELK4 (Barber
et al., 2012). However, ELK4 was dispensable for SIRT7 pro-
moter occupancy at other target promoters, including the pro-
moters of ribosomal protein genes, leaving open the question
of how SIRT7 is recruited to such promoters.
Recently, Myc has been shown to coordinate the transcrip-
tional control of ribosomal components and serve as a master
regulator of ribosome biogenesis (Kim et al., 2000; van Riggelen
et al., 2010). Chromatin remodeling is believed to be central to
Myc function in modulating the expression of its target genes
(Knoepfler et al., 2006; van Riggelen et al., 2010). Myc binding
on target chromatin is associated with the H3K18Ac mark, a
substrate of SIRT7 (Martinato et al., 2008). We therefore
hypothesized that Myc stabilizes SIRT7 at the promoters of ribo-
somal proteins to mediate chromatin remodeling and gene
repression. To probe a potential connection between Myc and
SIRT7, we tested whether SIRT7 physically interacts with Myc
in vivo. Western blot analysis of the immunoprecipitates fromovember 14, 2013 ª2013 The Authors 657
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Figure 3. SIRT7 Suppresses ER Stress
(A and B) Gene expression analysis by quantitative PCR (A) and western blotting (B) showing increased SIRT7 expression upon treatment of ER stress inducer
thapsigargin (TG) in WT, but not XBP1 KO, MEFs.
(C–F) Western blots (C) and quantitative PCR (D–F) showing reduced ER stress in tunicamycin-treated stable HepG2 cells overexpressing (OE) WT, but not
catalytically inactive (H187Y), SIRT7, as indicated by eIF2a phosphorylation levels and ER stress response gene expression.
(G) Western blots showing increased ER stress in SIRT7 knockdown (KD) stable HepG2 cells.
(legend continued on next page)
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Flag-tagged SIRT7-transfected cells revealed that Myc was
associated with Flag-SIRT7 (Figure 4A). Western blot analysis
of endogenous SIRT7 immunoprecipitates also revealed a
specific interaction with Myc (Figure 4B). Thus, SIRT7 physically
interacts with Myc in cells.
To investigate whether SIRT7 is stabilized at the promoters of
ribosomal proteins through its interactionwithMyc, we assessed
SIRT7 and Myc co-occupancy at these promoter regions.
Chromatin immunoprecipitation (ChIP) was performed with
SIRT7 and Myc antibodies to assess the genomic occupancy
of endogenous SIRT7 and Myc, compared to immunoglobulin
G (IgG)-negative background control. SIRT7 bound to the core
promoters of ribosomal proteins (Barber et al., 2012). Myc was
also detected at the same regions as SIRT7 on the core pro-
moters of ribosomal proteins, but not at the genomic region
6 kb upstream of the transcription start site (Figures 4C–4E; Fig-
ures S3A and S3B), consistent with the notion that Myc generally
occupies the core promoter regions of actively transcribed
genes (Lin et al., 2012). In contrast, Myc was not detected at
the promoters of NME1 and COPS2, where SIRT7 binding is
mediated through ELK4 (Figures 4F and S3C) (Barber et al.,
2012). Myc depletion using small interfering RNA (siRNA) led to
a significant reduction in SIRT7 occupancy at the promoters of
ribosomal proteins (Figures 4G, 4H, S3D, and S3E). However,
Myc depletion had no effect on SIRT7 occupancy at the pro-
moters of NME1 and COPS2 (Figures 4I and S3F). These data
suggest that Myc targets SIRT7 specifically to the promoters
of ribosomal proteins.
The specific association of SIRT7 andMyc at the promoters of
ribosomal proteins, but not at ELK4 target genes, suggests that
SIRT7 might specifically influence the expression of ribosomal
proteins via Myc. Therefore, we examined the effects of Myc
inhibition on SIRT7-mediated gene expression. As shown
previously, SIRT7 KD led to increased expression of ribosomal
proteins (Figures 4J and 4K) (Barber et al., 2012). Tunicamycin
treatment induced SIRT7 expression (Figures 3A and 3B; Figures
S2B–S2D) and suppressed the expression of ribosomal proteins
in control cells, but not in SIRT7 KD cells (Figures 4J and 4K),
indicating that ER stress triggers the transcriptional silencing of
ribosomal proteins and that this effect requires SIRT7. Strikingly,
Myc inactivation via siRNA or by a specific inhibitor, 10058-F4,
abrogated the elevated expression of ribosomal proteins, but
not NME1 in SIRT7 KD cells (Figures 4J, 4K, S3G, and S2H),
demonstrating that the observations on ribosomal proteins are
due to Myc-dependent effects of SIRT7 on gene expression.
Together, these data suggest that Myc targets SIRT7 specifically
to the promoters of ribosomal proteins for transcriptional
silencing.
The observation that ER stress represses ribosomal proteins
in a SIRT7-dependent manner suggests that upon ER stress,
the induction of SIRT7might function to suppress ribosomal pro-
tein expression and protein translation, in order to relieve ER(H and I) Increased ER stress in SIRT7 KOMEFs. Quantitative PCR showing incre
profiling showing a reduced polysome-to-monosome ratio, an ER stress marker
(J and K) SIRT7 prevents ER stress-induced cell death. Stable SIRT7 overexpre
treated with tunicamycin (2 mg/ml for J and 1 mg/ml for K) for 24 hr. Apoptosis w
Error bars represent SEM. * p < 0.05. ** p < 0.01. *** p < 0.001. See also Figure S
Cestress. To test this possibility, we assessed the effects of
suppressing Myc-mediated expression of ribosomal proteins
on SIRT7-associated ER stress management. Myc inactivation
by siRNA or 10058-F4 abrogated the increased ER stress in
SIRT7 KD cells (Figures 4K and S3I). Myc inactivation also blunt-
ed the effects of SIRT7 on ER stress resistance (Figures S3J and
S3K). Together, these results indicate that SIRT7 is targeted to
the promoters of ribosomal proteins by interacting with Myc
and alleviates ER stress by countering Myc-dependent expres-
sion of these genes.
ER Stress Underlies the Development of Fatty Liver
Caused by SIRT7 Deficiency
We next determined whether ER stress underlies the develop-
ment of fatty liver in SIRT7-deficient mice. SIRT7 KO livers
showed increased ER stress, as evidenced by the induction
of e-IF2a phosphorylation and ER stress response genes, as
well as a reduction in the polysome-to-monosome ratio (Figures
5A–5C). Reintroduction of SIRT7 in the livers of SIRT7 KO mice
via AAV8-mediated gene transfer reduced ER stress (Figure 5D)
and reverted the fatty liver phenotype (Figures 2A–2E). More-
over, treatment of SIRT7 KO mice with TUDCA, a small mole-
cule chaperone that has been shown to alleviate ER stress
in vivo (Ozcan et al., 2006), partially rescued the fatty liver
phenotype (Figures 5E and 5F). Finally, liver-specific Myc
knockdown in SIRT7 KO mice via AAV8-mediated gene transfer
reduced ER stress (Figures 6A and 6B), suppressed hepatic
inflammation and lipogenesis (Figures 6C and 6D), and
reversed the fatty liver phenotype (Figures 6D and 6E). Thus,
SIRT7 prevents the development of fatty liver by suppressing
ER stress.
SIRT7 Reverts Fatty Liver Associated with Diet-Induced
Obesity
A high-fat, high-calorie diet is associated with increased ER
stress and the development of fatty liver disease (Oyadomari
et al., 2008). We next asked whether SIRT7 could be targeted
to alleviate high-fat diet-induced ER stress and the develop-
ment of fatty liver disease. We overexpressed SIRT7 specifically
in the livers of mice fed a high-fat diet via AAV8-mediated gene
transfer. Consistent with previous reports (Oyadomari et al.,
2008), high-fat diet feeding led to an increase in ER stress
markers (Figures 7A and 7B), accumulation of TG in the liver
(Figures 7C–7E), possibly because of decreased VLDL secretion
and increased lipogenesis (Figures 7A and 7F), and increased
inflammation (Figures 7A and 7D). Strikingly, SIRT7 overexpres-
sion in the livers of high-fat-diet-fed mice suppressed ER stress
(Figures 7A and 7B), VLDL secretion (Figure 7F), lipogenesis
(Figure 7A), and inflammation (Figures 7A and 7D) and rescued
the fatty liver phenotype (Figures 7C–7E). Thus, SIRT7 activation
represents an attractive approach to revert ER stress-mediated
fatty liver.ased expression of ER stress-induced genes in SIRT7 KOMEFs (H). Polysome
indicative of translational initiation blockade (I).
ssion (OE) or knockdown (KD1 or KD2) cells used in Figures 3C and 3G were
as scored with Annexin V staining.
2.
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Figure 4. Myc Recruits SIRT7 to Repress the Expression of Ribosomal Proteins and to Suppress ER Stress
(A) Western analysis showing coIP of Flag-tagged SIRT7 and endogenous Myc in 293T cells.
(B) Western blots showing coIP of endogenous SIRT7 and Myc in Hep G2 cells.
(C–F) ChIP-qPCR (mean ± SEM) showing Myc occupancy at the RPS20 proximal promoter, but not 6 kb upstream, compared to IgG-negative control samples.
Myc occupancy at the g-tubulin and NME1 promoters was used as negative controls. All samples were normalized to input DNA.
(G) Western blots showing knockdown of Myc with siRNA in cells used in (H and I).
(H and I) Reduction of SIRT7 occupancy at the RPS20, but not the NME1, promoter in Myc knockdown cells determined by ChIP (mean ± SEM).
(legend continued on next page)
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Figure 5. SIRT7 Prevents the Development
of Fatty Liver by Suppressing ER Stress
(A–C) Western analysis (A), quantitative PCR (B),
and polysome profiling (C) showing increased ER
stress in SIRT7 KO livers.
(D) Quantitative PCR showing decreased expres-
sion of ER stress response genes in SIRT7 KO
livers by reintroduction of SIRT7 via AAV8-medi-
ated gene transfer.
(E and F) H&E, Oil Red O staining, and F4/80
staining of liver sections (E), and quantification of
liver triglyceride (F) showing a small molecule
chaperone TUDCA partially reverses fatty liver
phenotype of SIRT7 KO mice. n = 6.
Error bars represent SEM. * p < 0.05. ** p < 0.01.
*** p < 0.001.DISCUSSION
Our work uncovered a physiological role of SIRT7 in maintaining
hepatic metabolic homeostasis, demonstrated the feasibility of
targeting SIRT7 to restore metabolic homeostasis in animals
with metabolic disorders, and revealed a regulatory branch of
the UPR that is amenable for therapeutic targeting. The canoni-
cal UPR leads to the phosphorylation of eIF2a and the suppres-
sion of translation to alleviate ER stress (Ozcan and Tabas, 2012;
Walter and Ron, 2011). We show that SIRT7 is induced by XBP1
upon ER stress and is recruited to the promoters of ribosomal
proteins via Myc to repress gene expression and to alleviate
ER stress (Figure S4A). In SIRT7-deficient cells, failure to engage
SIRT7-mediated ER stress management results in constitu-
tive ER stress that induces activation of the canonical UPR(J) Western analysis showing Myc inactivation by a small molecule inhibitor abrogates increased expression o
KD cells used in Figure 3G.
(K) Western analysis showing Myc inactivation via siRNA abrogates ER stress and increased expression of rib
cells used in Figure 3G.
Error bars represent SEM. * p < 0.05. *** p < 0.001. ns: p > 0.05. See also Figure S3.
Cell Reports 5, 654–665, N(phosphorylation of eIF2a, blockade of
polysome assembly and translational initi-
ation, and induction of ER stress response
genes), apoptosis, and inflammation and,
specifically in the liver, increased lipogen-
esis and reduced VLDL secretion (Fig-
ure S4B). Importantly, SIRT7 upregulation
alleviates ER stress and restores hepatic
metabolic homeostasis in diet-induced
obese animals, providing an avenue to
treat fatty liver disease and likely other
ER stress-associated pathologies.
Our observation that SIRT7 opposes
Myc-dependent gene regulation is
intriguing. In addition to its role in fatty liver
pathology, the dynamic balance between
SIRT7 and Myc activities could play a
pivotal role in the context of tumorigen-
esis. SIRT7 may keep the Myc oncogene
in check to prevent tumorigenesis. How-ever, under certain conditions, Myc can also trigger apoptosis
as an evolved tumor defensemechanism (Evan et al., 1992; Sou-
cek and Evan, 2010). Our study suggests that unopposed Myc
activation in the absence of SIRT7 results in ER stress. This
may be an underlying mechanism for Myc-induced apoptosis
in cancer cells that are particularly sensitive to ER stress (Ozcan
and Tabas, 2012). Indeed, we find that SIRT7 prevents ER
stress-induced cell death in a Myc-dependent manner (Figures
S3J and S3K). These observations are consistent with previous
findings that SIRT7 can promote cancer cell survival and main-
tain oncogenic transformation (Barber et al., 2012).
Our findings regarding the role of SIRT7 in ER stress
management might also be important for aging biology. Indeed,
SIRT7 has several potential links to aging. SIRT7 KO mice
have shortened life spans and exhibit phenotypes linked tof ribosomal proteins, but not NME1, in stable SIRT7
osomal proteins, but not NME1, in stable SIRT7 KD
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Figure 6. SIRT7 Suppresses ER Stress and
Prevents the Development of Fatty Liver by
Repressing Myc
(A–E) Data shown are the comparison of WT,
SIRT7 KO, and SIRT7 KO mice with Myc knock-
down in livers via AAV8-mediated gene transfer.
(A) Myc expression by quantitative PCR. (B) ER
stress in the livers by western analysis. (C) Quan-
titative PCR analysis for the expression of inflam-
mation, lipogenesis, and fatty acid oxidation
genes. (D) H&E, Oil Red O staining, and F4/80
staining of liver sections. (E) Liver triglyceride
quantification. n = 5.
Error bars represent SEM. * p < 0.05. ** p < 0.01.
*** p < 0.001. ns: p > 0.05. See also Figure S4.aging (Vakhrusheva et al., 2008). Furthermore, SIRT7 expression
decreases in some aging tissues (Vakhrusheva et al., 2008). Sup-
pression of ribosomal proteins and ER stress leads to life span
extension in yeast (Steffen et al., 2012). Thus, the interplay be-
tween SIRT7, ER stress, and protein translation may represent
an evolutionarily conserved phenomenon in aging.EXPERIMENTAL PROCEDURES
Mice
Sirt7/ mice were produced by the VelociGene method (Valenzuela et al.,
2003) (VelociGene allele identification number: VG321). The SIRT7 KO-target-
ing vector was constructed by replacing exons 4 to 11 with a LacZ gene
inserted in-frame after the first few base pairs of exon 4 (Figures 1A
and 1B). An Srf1-linearized targeting vector (30 mg) was electroporated into
CJ7,129SJ ES cells as described previously (Valenzuela et al., 2003). Positives
clones were identified by Taqman analysis (Valenzuela et al., 2003) and
confirmed by Southern blot analysis in which genomic DNA was digested662 Cell Reports 5, 654–665, November 14, 2013 ª2013 The Authorswith Kpn1 and the membranes were probed with
a 500 bp fragment covering exons 1–3. Chimeric
mice were generated by injection of targeted ES
clones into C57BL6/J blastocysts. Male chimeras
were mated with 129Sv females to generate F1
heterozygous mice, which were interbred to
generate homozygous KO mice, which were
screened by Southern blotting as described above
(Figure S1A).
All mice were housed on a 12:12 hr light:dark
cycle at 25C. Experiments were performed using
4- to 6-month-old male littermates. Mice were
randomized into each of the groups. Samples
were processed blindly during the experiments,
and the outcome was assessment. All animal
procedures were in accordance with the animal
care committee at the University of California,
Berkeley. The high-fat diet was provided by
OpenSource Diets (D12079B). For TUDCA treat-
ment, mice received intraperitoneal injections of
500 mg/kg/day TUDCA or PBS twice daily for
20 days as described previously (Cnop et al.,
2012). VLDL-TG secretion assay was performed
as described previously (Haeusler et al., 2010).
Blood was collected from the mouse tail vein
and kept on ice until centrifugation (1,500 g,
15 min at 4C). VLDL concentration was quanti-
fied as described using a gas-phase differentialelectrical mobility analyzer (Caulfield et al., 2008). Plasma triglyceride
was measured in accordance with the manufacturer’s instruction (Wako
Diagnostics). Triglycerides were extracted from liver tissues as described
and were extracted from feces as described (Zadravec et al., 2010).
Extracted triglyceride was quantified in accordance with the manufacturer’s
instruction (Wako Diagnostics). Liver tissues were processed for H&E stain-
ing, Oil Red O staining, and F4/80 staining as described previously (Sun
et al., 2012).
For AAV-mediated gene transfer to the mouse liver, SIRT7 or Myc knock-
down target sequence was cloned into dsAAV-RSVeGFP-U6 vector. dsAAV8
was produced by triple-transfection and CsCl purification, and virus titer
was determined as previously described (Gao et al., 2006). Each mouse was
injected with 3 3 1011 genome copies of virus via tail vein.
Cell Culture, RNAi, and Viral Transduction
293T, Hepa 1-6, and Hep G2 cells were acquired from the American Type
Culture Collection. WT and SIRT7 KO MEFs were generated in accordance
with standard procedures (Greber et al., 2007). XBP-1 KO MEFs were ac-
quired from L. Glimcher (Lee et al., 2008). Cells were cultured in advanced
Dulbecco’s modified Eagle’s medium (Invitrogen) supplemented with 1%
Figure 7. SIRT7 Rescues High-Fat Diet-Induced Fatty Liver
(A–F) Data shown are a comparison of livers of mice fed a chow diet, a high-fat diet, and a high-fat diet with SIRT7 reintroduced specifically in the liver via AAV8-
mediated gene transfer. (A) Quantitative PCR analyses for gene expression of ER stress, inflammation, and lipogenesis. (B) Western blotting for ER stress
markers. (C) Morphology. (D) H&E staining, Oil Red O staining, and F4/80 staining. (E) Quantification of liver triglyceride. (F) A VLDL-TG secretion assay. n = 6.
Error bars represent SEM. ** p < 0.01. *** p < 0.001.penicillin-streptomycin (Invitrogen) and 10%FBS (Invitrogen). For ER stress in-
duction, cells were treated with tunicamycin (Sigma, 1 mg/ml) or thapsigargin
(Sigma, 0.1 mM) for 24 hr for biochemical analysis or 48 hr for cell survival anal-
ysis. Cells were treated with 0.5 mMstaurosporin for 48 hr for cell survival anal-Ceysis. Cell survival was scored with trypan blue staining or Annexin V staining
(Biolegend). For Myc inactivation, cells were treated with 10058-F4 (Sigma,
2 mM) for 24 hr before analysis. Cellular NAD+ concentration was quantified
using EnzyChrom NAD/NADH Assay Kit (Bioassay System).ll Reports 5, 654–665, November 14, 2013 ª2013 The Authors 663
SIRT7 knockdown target sequences are as follows, as previously described
(Barber et al., 2012):
S7KD1, 50-CACCTTTCTGTGAGAACGGAA-30,
S7KD2, 50-TAGCCATTTGTCCTTGAGGAA-30.
Myc knockdown target sequences are as follows, as previously described
(Caulfield et al., 2008):
Myc KD (human), 50- GGACTATCCTGCTGCCAAG -30,
Myc KD (mouse), 50- CCCAAGGTAGTGATCCTCAAA-30.
Double-stranded siRNAs were purchased from Thermo Scientific and
were transfected into cells via RNAiMax (Invitrogen) in accordance with the
manufacturer’s instruction.
For lentiviral packaging, 293T cells were cotransfected with packaging
vectors (pCMV-dR8.2 dvpr and pCMV-VSV-G) and the pSiCoR-SIRT7
knockdown or empty construct. For retroviral packaging, 293T cells were
cotransfected with packaging vectors (pVPack-VSV-G, pVPack-GP) and
pBABE-SIRT7, pBABE-SIRT7 H187Y, or empty construct. Viral supernatant
was harvested after 48 hr. For transduction, cells were incubated with virus-
containing supernatant in the presence of 8 mg/ml polybrene. After 48 hr,
infected cells were selected with puromycin (1 mg/ml).
Coimmunoprecipitations
Coimmunoprecipitations (coIPs) were performed as previously described
(Qiu et al., 2010) with Flag-resin (Sigma) or Protein A/G beads (Santa Cruz)
for SIRT7 IP. Elution was performed with either Flag peptide (Sigma) or
100 mM Glycine solution (pH 3) for SIRT7 IP. Antibodies are provided in
Table S1.
ChIP and mRNA Analysis
Cells were prepared for ChIP as previously described (Dahl and Collas, 2007),
with the exception that DNA was washed and eluted using a PCR purification
kit (QIAGEN) rather than by phenol-chloroform extraction. RNA was isolated
from cells or tissue using Trizol reagent (Invitrogen) and purified using the
RNeasy Mini Kit (QIAGEN). cDNA was generated using the qScript cDNA
SuperMix (Quanta Biosciences). Gene expression was determined by real-
time PCR using Eva quantitative PCR (qPCR) SuperMix Kit (BioChain Institute)
on an ABI StepOnePlus system. All data were normalized to ActB or GAPDH
expression. Antibodies and PCR primer details are provided in Tables S1,
S2, and S3.
Polysomal Profiling
MEFs or liver tissues were collected for polysomal profiling as described (Zid
et al., 2009). Briefly, ten million MEF cells or 0.1 g of liver were harvested and
homogenized on ice in 400 ml of solublization buffer (300 mM NaCl, 50 mM
Tris-HCl [pH 8.0], 10 mM MgCl2, 1 mM EGTA, 200 mg/ml heparin, 1 mM
DTT, 400 U/ml RNAsin plus (Promega), 1X complete, Mini Protease Inhibitor
Cocktail (Roche), 0.2 mg/ml cycloheximide, 1% Triton X-100, and 0.1%
aodium deoxycholate). Additional solubilization buffer was added for a total
of 1ml. Cell lysate was placed back on ice for 10 min before centrifuging at
16,000 g for 15 min at 4C. The supernatant was applied to the top of a
10%–50% continuous sucrose gradient in high salt resolving buffer
(140 mM NaCl, 25 mM Tris-HCl [pH 8.0], and 10 mM MgCl2) and centrifuged
in a Beckman SW41Ti rotor (Beckman Coulter) at 180,000 g for 90 min at 4C.
Gradients were fractionated with continuous monitoring of absorbance at
254 nm.
Statistical Analysis
The number of mice chosen for each experiment is based on the principle that
the minimal number of mice is used to have sufficient statistical power and
is comparable to published literature for the same assays performed. No
animals were excluded from the analyses. Student’s t test was used for
data analysis. Error bars represent SE. In all corresponding figures, * repre-
sents p < 0.05. ** represents p < 0.01. and *** represents p < 0.001. ns
represents p > 0.05.664 Cell Reports 5, 654–665, November 14, 2013 ª2013 The AuthorsSUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and three tables and can be
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